US Patent 7456218 3-(4-benzyloxyphenyl) propanoic acid derivatives
Patent 7456218 was granted and assigned to Takeda Pharmaceutical Company on November, 2008 by the United States Patent and Trademark Office.
All edits
The present invention provides a novel compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof having a superior GPR40 receptor function modulating action, which can be used as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. They unexpectedly show superior GPR40 receptor agonist activity, and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful pharmaceutical agents for the prophylaxis or treatment of GPR40 receptor related diseases in mammals.
US Patent 07456218 3-(4-benzyloxyphenyl) propanoic acid derivatives US Patent 7456218 3-(4-benzyloxyphenyl) propanoic acid derivatives
US Patent 07456218 3-(4-benzyloxyphenyl) propanoic acid derivatives
Find more entities like US Patent 7456218 3-(4-benzyloxyphenyl) propanoic acid derivatives
